Diabetes prevalence continues to increase in the lowest income areas, calling for more tailored and culturally sensitive policy interventions and programs to reduce the future burden of diabetes among populations living with social disadvantage.
Abstract
Background
The rising prevalence of diabetes disproportionately impacts socially-disadvantaged communities. We aimed to determine whether trends of diabetes prevalence vary by age, sex, and neighbourhood socioeconomic status (SES).
Methods
We conducted a population-based cross-sectional time-series analysis using health administrative data for adults aged ≥20 years (>90% type 2 diabetes) from 2015 (N=10,935,448) to 2021 (N=11,885,060). Annual crude and age-sex standardized prevalence rates were estimated using a validated administrative case definition. Neighbourhood SES was measured using the Material Deprivation Domain of the Ontario Marginalization Index and categorized into quintiles (Q1 least deprived to Q5 most deprived).
Results
Age-sex standardized prevalence of diabetes increased nearly 6% from 10.8 in 2015 to 11.4% in 2021. Increases were consistent across all age and sex groups, with the largest relative increases among adults aged 20-34 years (males +17.1%, females +11.3%). Diabetes prevalence rose across all neighbourhood deprivation quintiles, remaining highest in the most deprived areas from 2015 to 2021 (13.3% to 14.1%). Relative increases ranged from 5.8% in the most deprived areas to 7.1% in the least deprived areas. A clear socioeconomic gradient was observed where diabetes prevalence was 42% higher in the most deprived neighbourhoods (Q5 RR 1.42, 95% CI 1.41-1.44; all p<0.0001) compared to the least (Q1) deprived areas, underscoring the structural nature of diabetes inequities.
Conclusions
Diabetes prevalence continues to increase in the lowest income areas, calling for more tailored and culturally sensitive policy interventions and programs to reduce the future burden of diabetes among populations living with social disadvantage.
Background
Type 2 diabetes mellitus (T2DM) is an escalating global health crisis among aging populations, warranting a comprehensive epidemiological assessment to support evidence-based policy development.
Methods
Using data from the Global Burden of Disease Study 2021, we examined age-standardized rates of prevalenc...
F. Xie, Ji-Gui Chen, Shaihong Zhu et al.· Endocrinology and Metabolism· 0 citations
Aim To examine trends in type 2 diabetes mellitus (T2DM) burden among adults aged ≥ 55 years in Mexico from 1990 to 2021, disaggregated by sex, quinquennial age groups, and subnational level. Materials and Methods We conducted a secondary analysis of Global Burden of Disease (GBD) 2021 data. Age‐specific and age‐standa...
C. Dávila-Cervantes, M. Agudelo-Botero· Journal of Diabetes Research· 0 citations
Aims: Comorbidities are common at diabetes onset and may influence long-term outcomes. We examined national trends in the prevalence, number, and multimorbidity patterns among U.S. adults with newly ascertained diabetes, distinguishing concordant metabolic risk factors, concordant vascular diseases, and discordant cond...
Stephen J. Onufrak, Ibrahim Zaganjor, Daesung Choi et al.· Diabetes Research and Clinic...· 0 citations
The prevalence of obesity has been rising in the United States over the past decades. It is a major contributor to all-cause mortality, cancers, cardiovascular disease, diabetes, and other morbidities. It also contributes to increased health care costs. The aim of this study is to estimate trends in the prevalence of o...
Aaron B. Caughey· Obstetrical & Gynecologi...· 0 citations
Background: Chronic obstructive pulmonary disease (COPD) can show declining age-standardized rates while the number of affected people grows. We quantified this divergence and its demographic and socioeconomic pattern across Asia. Methods: Using Global Burden of Disease 2023 estimates for 48 Asian locations (2009–2023)...
Qin Luo, Yao Chen, Wu Yang et al.· International Journal of COP...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.